Filter
2083
Filtered Results: 2083
Text search:
drug
market
Featured
Recommendations
169
New Publications
622
Language
Document type
No document type
1241
Studies & Reports
352
Guidelines
256
Strategic & Response Plan
89
Manuals
78
Fact sheets
30
Training Material
18
Situation Updates
8
Resource Platforms
7
Infographics
2
App
1
Online Courses
1
Countries / Regions
India
116
Global
77
Kenya
72
Ethiopia
68
Uganda
68
Nigeria
50
Western and Central Europe
47
Bangladesh
43
Liberia
42
Ghana
42
Myanmar / Burma
39
Sierra Leone
36
Malawi
36
Nepal
35
Tanzania
31
Zambia
30
South Africa
30
Africa
30
Rwanda
28
Zimbabwe
24
Philippines
23
Ukraine
22
South–East Asia Region
21
Latin America and the Carribbean
20
Cambodia
19
Namibia
19
Congo, Democratic Republic of
17
Lesotho
16
Asia
15
Eastern Europe
15
Botswana
14
Indonesia
12
Russia
12
Senegal
11
Syria
11
Brazil
10
Venezuela
10
Burkina Faso
9
Mozambique
9
Guinea
8
Cameroon
7
Thailand
7
Albania
7
USA
6
Haiti
6
Eswatini/ Swaziland
6
East and Southern Africa
6
Eastern Europe and Central Asia
6
China
5
Sudan
5
West and Central Africa
5
Middle East and North Africa
5
Vietnam
5
South Sudan
4
Germany
4
Colombia
4
Sri Lanka
4
Laos
4
Georgia
4
Lebanon
3
Benin
3
Peru
3
North Macedonia
3
Libya
3
Mexico
3
Western Pacific Region
3
Timor Leste/ East Timor
3
Tajikistan
3
Moldova
3
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Central African Republic
2
Argentina
2
Hungary
2
Chile
2
Bhutan
2
Poland
2
Iran
2
Kyrgyzstan
2
Morocco
1
Afghanistan
1
Turkey
1
Papua New Guinea
1
Serbia
1
Bolivia
1
Madagascar
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
884
Clinical Guidelines
151
Public Health
110
Women & Child Health
61
Key Resources
48
Pharmacy & Technologies
43
Capacity Building
17
Toolboxes
HIV
210
Mental Health
180
AMR
159
TB
126
Pharmacy
119
COVID-19
93
NCDs
44
NTDs
39
Planetary Health
32
Ebola
30
Conflict
28
Rapid Response
27
Global Health Education
26
Refugee
24
Caregiver
23
Disability
22
Health Financing Toolbox
21
Cholera
9
Natural Hazards
8
Polio
4
Specific Hazards
4
Social Ethics
4
Zika
1
Health Financing
1
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Strengthening resource tracking and monitorig health expanditure
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the ...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the global HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of t...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public health issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwid...
